These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6385654)

  • 1. Overview: clinical experiences with ticlopidine.
    Day HJ
    Agents Actions Suppl; 1984; 15():297-309. PubMed ID: 6385654
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticlopidine: quo vadis? Subarachnoid hemorrhage.
    Ono H; Mizukami M; Kitamura K; Kikuchi H
    Agents Actions Suppl; 1984; 15():259-72. PubMed ID: 6385650
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises.
    Cabannes R; Lonsdorfer J; Castaigne JP; Ondo A; Plassard A; Zohoun I
    Agents Actions Suppl; 1984; 15():199-212. PubMed ID: 6385647
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the antithrombotic efficacy of ticlopidine in man.
    Panak E; Blanchard J; Roe RL
    Agents Actions Suppl; 1984; 15():148-66. PubMed ID: 6385644
    [No Abstract]   [Full Text] [Related]  

  • 5. Ticlopidine and coronary surgery.
    Limet R; David JL; Rigo P
    Agents Actions Suppl; 1984; 15():188-98. PubMed ID: 6385646
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic effect of ticlopidine for ischemic leg ulcers.
    Katsumura T
    Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645
    [No Abstract]   [Full Text] [Related]  

  • 7. The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics.
    Hass WK; Kamm B
    Agents Actions Suppl; 1984; 15():273-8. PubMed ID: 6385651
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis.
    Lonsdorfer J; Castaigne JP; Lenormand E; Otayeck A; Bogui P; Dosso Y; Cabannes R
    Agents Actions Suppl; 1984; 15():213-8. PubMed ID: 6592944
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind trial of ticlopidine in sickle cell disease.
    Semple MJ; Al-Hasani SF; Kioy P; Savidge GF
    Thromb Haemost; 1984 Jul; 51(3):303-6. PubMed ID: 6388012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of ticlopidine on the natural course of retinal vein occlusion.
    Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
    Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of ticlopidine on peripheral obliterating arteriopathy].
    Stiegler H; Hess H; Mietaschk A; Trampisch HJ; Ingrisch H
    Dtsch Med Wochenschr; 1984 Aug; 109(33):1240-3. PubMed ID: 6381015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the unmodified vessels after aortocoronary bypass surgery].
    Goebel N; Pfluger N; Speiser K; Turina M; Rothlin M
    Rofo; 1983 Dec; 139(6):595-602. PubMed ID: 6421685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study.
    Tohgi H
    Agents Actions Suppl; 1984; 15():279-82. PubMed ID: 6385652
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platelet release proteins in plasma in peripheral arterial obliterative disease during ticlopidine administration].
    Klingemann HG; Egbring R
    Dtsch Med Wochenschr; 1982 Sep; 107(37):1388-91. PubMed ID: 7117151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of oral drugs for intermittent claudication of the legs in phase III clinical trials. Options selected for the ACT study].
    Destors JM; Arcan JC
    Therapie; 1985; 40(6):451-8. PubMed ID: 4089787
    [No Abstract]   [Full Text] [Related]  

  • 16. Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study).
    Mirouze J
    Agents Actions Suppl; 1984; 15():230-58. PubMed ID: 6385649
    [No Abstract]   [Full Text] [Related]  

  • 17. Does extracorporeal circulation harm the brain?
    Smith WS; Mapstone M
    Neurology; 2005 Oct; 65(7):978-9. PubMed ID: 16217045
    [No Abstract]   [Full Text] [Related]  

  • 18. Spinal subarachnoid hematoma after lumbar puncture in a patient receiving antiplatelet therapy.
    Mayumi T; Dohi S
    Anesth Analg; 1983 Aug; 62(8):777-9. PubMed ID: 6869865
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo.
    Katsumura T; Mishima Y; Kamiya K; Sakaguchi S; Tanabe T; Sakuma A
    Angiology; 1982 Jun; 33(6):357-67. PubMed ID: 7046521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of ticlopidine in chronic hemodialyzed patients. Counter-indication in future renal transplant receivers].
    Lang P; Plaisant B; Benoit G; Brasseur L; Charpentier B; Fries D
    Presse Med; 1985 Apr; 14(16):894-5. PubMed ID: 3158926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.